Opipramol 1 A Pharma (Opipramol Hydrochloride)

Opipramol is an anxiolytic that acts on central nervous system pathways involved in anxiety and mood regulation.

• Generalized Anxiety Disorder: reduces excessive worry and tension.
• Somatoform Disorder: alleviates medically unexplained physical symptoms linked to anxiety.
• Depressive Disorder (adjunct): improves mood and sleep when used alongside other antidepressants.

• Opipramol exerts its therapeutic effect primarily through agonism at sigma‑1 receptors, which modulates neurotransmitter release and neuronal excitability. It also inhibits the reuptake of serotonin and norepinephrine and displays antihistaminic and anticholinergic activity, contributing to its anxiolytic and sedative properties.

Opipramol may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Drowsiness: feeling unusually sleepy or fatigued.
• Dry mouth: reduced salivation leading to discomfort.
• Constipation: infrequent or difficult bowel movements.
• Dizziness: light‑headed sensation, especially on standing.
• Weight gain: gradual increase in body weight.
• Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects

• Cardiac arrhythmia: irregular heart rhythm requiring medical attention.
• Severe hypotension: marked drop in blood pressure causing faintness.
• Seizures: convulsive episodes in susceptible individuals.
• Hepatic dysfunction: abnormal liver enzymes or hepatitis.
• Agranulocytosis: dangerously low white‑blood‑cell count.
• Suicidal ideation: emergence of thoughts of self‑harm.

Before initiating Opipramol therapy, consider the following safety measures.

• Cardiac assessment: evaluate history of heart disease or arrhythmias.
• Liver monitoring: perform baseline and periodic liver function tests.
• Gradual discontinuation: taper the dose to avoid withdrawal symptoms.
• Elderly caution: start at lower doses due to increased sensitivity.
• Alcohol avoidance: refrain from consuming alcohol as it may enhance sedation.
• Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Opipramol can interact with several medication classes; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.
• Central nervous system depressants (e.g., benzodiazepines, opioids): additive sedation and respiratory depression.
• Alcohol: potentiates sedative effects and impairs coordination.

Moderate Interactions (Monitor Closely)

• Antihistamines: may increase drowsiness.
• Anticholinergic agents: enhance dry‑mouth and constipation.
• CYP450 inhibitors (e.g., fluoxetine): can raise Opipramol plasma levels.
• CYP450 inducers (e.g., carbamazepine): may reduce therapeutic effect.
• Antihypertensives: monitor blood pressure for additive hypotensive effect.